全文获取类型
收费全文 | 114952篇 |
免费 | 9884篇 |
国内免费 | 6648篇 |
专业分类
耳鼻咽喉 | 1207篇 |
儿科学 | 1642篇 |
妇产科学 | 819篇 |
基础医学 | 10987篇 |
口腔科学 | 2057篇 |
临床医学 | 12282篇 |
内科学 | 17294篇 |
皮肤病学 | 1466篇 |
神经病学 | 5896篇 |
特种医学 | 4791篇 |
外国民族医学 | 25篇 |
外科学 | 14026篇 |
综合类 | 21059篇 |
现状与发展 | 27篇 |
一般理论 | 10篇 |
预防医学 | 9408篇 |
眼科学 | 2011篇 |
药学 | 11415篇 |
106篇 | |
中国医学 | 6242篇 |
肿瘤学 | 8714篇 |
出版年
2024年 | 312篇 |
2023年 | 1161篇 |
2022年 | 3069篇 |
2021年 | 4437篇 |
2020年 | 3338篇 |
2019年 | 2765篇 |
2018年 | 2974篇 |
2017年 | 3152篇 |
2016年 | 3149篇 |
2015年 | 4799篇 |
2014年 | 6127篇 |
2013年 | 6444篇 |
2012年 | 9631篇 |
2011年 | 10332篇 |
2010年 | 8053篇 |
2009年 | 6853篇 |
2008年 | 7960篇 |
2007年 | 7959篇 |
2006年 | 7170篇 |
2005年 | 6441篇 |
2004年 | 4852篇 |
2003年 | 4583篇 |
2002年 | 3904篇 |
2001年 | 2499篇 |
2000年 | 1977篇 |
1999年 | 1361篇 |
1998年 | 779篇 |
1997年 | 779篇 |
1996年 | 545篇 |
1995年 | 492篇 |
1994年 | 425篇 |
1993年 | 267篇 |
1992年 | 355篇 |
1991年 | 339篇 |
1990年 | 250篇 |
1989年 | 264篇 |
1988年 | 238篇 |
1987年 | 216篇 |
1986年 | 189篇 |
1985年 | 159篇 |
1984年 | 119篇 |
1983年 | 81篇 |
1982年 | 54篇 |
1980年 | 43篇 |
1979年 | 54篇 |
1978年 | 46篇 |
1975年 | 39篇 |
1973年 | 40篇 |
1972年 | 45篇 |
1969年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
射频消融治疗肝肿瘤315例报告 总被引:16,自引:1,他引:15
目的总结1999年6月至2003年8月用射频消融(radiofrequency ablation,RFA)治疗315例肝肿瘤病人的病例资料,探索RFA治疗肝肿瘤近远期疗效。方法采用了一次定位、多点穿刺,RFA联合肝动脉栓塞(TAE)、选择性门静脉栓塞(SPVE)治疗直径5~13cm的大肝癌,及经皮经肺经膈肌RFA治疗膈顶部肝癌。结果总并发症发生率为5.1%,无一例住院期间死亡。AFP阳性的169例肝癌病人中,RFA后有124例(73.6%)明显降低,其中有95例(56.2%)转阴。半年生存率为89.5%,1年生存率为80.1%,18个月生存率为61.4%,24个月生存率为48.3%,〉36个月生存率为35.6%。结论采用TAE、SPVE及RFA一次定位多点穿刺法治疗无手术切除指征的中晚期(含大肝癌)的病人,疗效明显,总并发症发生率低。 相似文献
82.
目的检测瘢痕疙瘩、增生性瘢痕和正常皮肤组织中转化生长因子-β1(TGF-β1)、Smad3和P-Smad2/3的表达情况,探讨上述细胞因子对瘢痕产生的重要性及影响。方法采用免疫组织化学的方法检测上述3种细胞因子在3种不同组织共36例标本中的表达,ImagePro-Plus6.0软件进行阳性面积测量和细胞计数。结果TGF-β1在瘢痕疙瘩和增生性瘢痕中均为增强高表达,而在正常皮肤中几乎不表达;Smad3在三组标本间表达水平无显著性差异;P-Smad2/3在瘢痕疙瘩中表达最强,增生性瘢痕次之,正常皮肤组织中最低。结论TGF-β1表达增强是病理性瘢痕产生的重要原因,P-Smad2/3的表达水平则可认为与瘢痕增生程度密切相关。 相似文献
83.
Kazuaki Shimamoto Toru Kita Hiroshi Mabuchi Masunori Matsuzaki Yuji Matsuzawa Noriaki Nakaya Shinichi Oikawa Yasushi Saito Jun Sasaki Hiroshige Itakura 《Hypertension research》2007,30(2):119-123
Hyperlipidemia, hypertension, and diabetes mellitus (DM) are well-established risk factors for cardiovascular disease. We analyzed the cardiovascular events in hyperlipidemic patients with or without DM who were administered open-labeled simvastatin in groups stratified by blood pressure level using data from the Japan Lipid Intervention Trial (J-LIT). Hyperlipidemic patients with DM (n=6,288) had significantly more cardiovascular events than those without DM (n=33,933). The incidence rates of total cardiovascular events in the Non-DM and DM groups were 15.40 and 25.76 per 1,000 patients for the 6-year period, respectively. The relative risk of total cardiovascular events in the DM vs. the Non-DM group was 1.68, and the relative risk was significantly higher in the DM than in the Non-DM group. The relative risks of total cardiovascular events were significantly higher in DM and Non-DM patients whose systolic blood pressure (SBP) was greater than or equal to 130 mmHg compared to that of Non-DM patients whose SBP was less than 130 mmHg, and in DM and Non-DM patients whose diastolic blood pressure (DBP) was greater than or equal to 80 mmHg compared to that of Non-DM patients whose DBP was less than 80 mmHg. In all groups stratified by SBP and DBP, relative risks of total cardiovascular events were higher in DM patients than in Non-DM patients. For patients with hypercholesterolemia and DM, blood pressure should be strictly controlled in order to prevent both coronary events and stroke. These results are in good agreement with the JNC 7 and the ESH/ESC guidelines for DM patients, which recommended that the SBP and DBP be less than 130 and 80 mmHg, respectively. 相似文献
84.
85.
目的 探讨重症急性胰腺炎(SAP)早期治疗体会及外科手术治疗时机和手术方式的选择。方法 对比分析1989—1995年以早期手术为主的36例SAP(A组)与1996—2003年7年中非手术治疗为主的44例SAP(B组)的治愈率和死亡率。结果 B组的死亡率明显低于A组,A组的治愈率低于B组。结论 SAP早期的急性炎症反应期,手术只能加重对机体的打击,加重SAP全身炎症反应,增加手术死亡率。故SAP早期治疗应以非手术疗法为主。当内科治疗无效,手术治疗是唯一的选择,而手术时机的掌握和手术方式的选择更为重要,直接影响手术结果。 相似文献
86.
87.
目的:评价乳胶结合实验,检测重症监护病房(ICU)耐甲氧西林金黄色葡萄球菌(MRSA)及其肠毒素(SE),并进行耐药性分析。方法:收集260株金黄色葡萄球菌临床分离株,通过药敏试验将其分为耐甲氧西林金黄色葡萄球菌和甲氧西林敏感金黄色葡萄球菌(MSSA),用反向间接血凝试验(RPHA)检测金黄色葡萄球菌肠毒素。结果:MRSA产肠毒素为134株,MSSA产肠毒素为38株,MRSA产肠毒素率为100%,MSSA产肠毒素率为30%。结论:重症监护病房应重视MRSA的检测和金黄色葡萄球菌肠毒素的检测,合理使用广谱抗菌药物。 相似文献
88.
Hiroko Utsunomiya Wanninayake M. Tilakaratne Kazufumi Oshiro Satoshi Maruyama Makoto Suzuki Hiroko Ida-Yonemochi Jun Cheng Takashi Saku 《Journal of oral pathology & medicine》2005,34(8):498-507
BACKGROUND: Oral submucous fibrosis (OSF) is a chewing habit-related pre-cancerous condition of the oral mucosa affecting predominantly south Asians. It is histopathologically characterized by epithelial atrophy and fibrosis of the subepithelial connective tissue. Fibrosis extends all the way into the muscle layer, leading to difficulty in mouth opening. However, the dynamics of extracellular matrix (ECM) remodeling with OSF progression is largely unknown. METHODS: Forty biopsy specimens of OSF and 10 of normal buccal mucosa were examined for expression/deposition modes of eight ECM molecules by histochemistry, immunohistochemistry, and in situ hybridization. RESULTS: In the early stage of OSF, tenascin, perlecan, fibronectin, collagen type III were characteristically enhanced in the lamina propria and the submucosal layer. In the intermediate stage, the ECM molecules mentioned above and elastin were extensively and irregularly deposited around muscle fibers. In the advanced stage, such ECM depositions decreased and were entirely replaced with collagen type I only. Their gene expression levels varied with progression of fibrosis, but the mRNA signals were confirmed in fibroblasts in the submucosal fibrotic areas. CONCLUSIONS: The results indicate that the ECM remodeling steps in OSF are similar to each phase of usual granulation tissue formation. Restricted mouth opening may be a result of loss of variety of ECM molecules including elastin into the homogeneity of collagen type I replacing muscle fibers. 相似文献
89.
综合疗法治疗乳腺增生62例 总被引:1,自引:0,他引:1
我科于2005年6月~2006年12月用乳癖消结合逍遥丸内服、耳穴埋压治疗乳腺增生62例,获得满意疗效,现介绍如下。 相似文献
90.
Lijun Di Jun Ren Ying Yan 《中德临床肿瘤学杂志》2007,6(4):393-395
Objective: To evaluate the effect and safety of clinical use of zoledronic acid in the treatment of malignant hypercalcemia. Methods: A multi-center, open phase II clinical trial was conducted in 15 cases with malignant hypercalcemia who received zoledronic acid intravenously for 15 min. The level of blood calcium and side effects were recorded regularly within 28 days after injection. Results: One case was dropped out due to bad compliance. The complete response rate (the corrected serum calcium was reduced to normal level) was 100.00% (14/14). The medium time of complete response rate was 5.07 days. The medium maintain time was 22.30 days. Slight, or moderate fever was observed. Conclusion: Zoledronic acid can effectively reduce the malignant hypercalcemia. The use of zoledronic acid appears to be safety and convenient. 相似文献